Inositol Nicotinate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08949 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | vitamin deficiency disorder | KG + DL |
| 2 | biotin metabolic disease | KG + DL |
| 3 | non-syndromic esophageal malformation | KG + DL |
| 4 | iron deficiency anemia | KG + DL |
| 5 | acute urate nephropathy | KG + DL |
| 6 | esophageal disease | KG + DL |
| 7 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 8 | hepatoportal sclerosis | KG + DL |
| 9 | primitive portal vein thrombosis | KG + DL |
| 10 | idiopathic copper-associated cirrhosis | KG + DL |
| 11 | hepatopulmonary syndrome | KG + DL |
| 12 | hepatic porphyria | KG + DL |
| 13 | congenital prothrombin deficiency | KG + DL |
| 14 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 15 | muscular atrophy | KG + DL |
| 16 | nephrolithiasis | KG + DL |
| 17 | folic acid deficiency anemia | KG + DL |
| 18 | uterine inflammatory disease | KG + DL |
| 19 | Ureaplasma urethritis | KG + DL |
| 20 | gonococcal urethritis | KG + DL |
| 21 | urinary tract infection (disease) | KG + DL |
| 22 | pregnancy associated osteoporosis | KG + DL |
| 23 | protein-energy malnutrition | KG + DL |
| 24 | xanthogranulomatous pyelonephritis | KG + DL |
| 25 | postmenopausal osteoporosis | KG + DL |
| 26 | Keshan disease | KG + DL |
| 27 | inborn error of biotin metabolism | KG + DL |
| 28 | myopathic intestinal pseudoobstruction | KG + DL |
| 29 | unclassified intestinal pseudoobstruction | KG + DL |
| 30 | bile duct neoplasm | KG + DL |
| 31 | magnesium deficiency | KG + DL |
| 32 | motor neuron disease | KG + DL |
| 33 | choline deficiency disease | KG + DL |
| 34 | potassium deficiency | KG + DL |
| 35 | swayback | KG + DL |
| 36 | bulbospinal muscular atrophy | KG + DL |
| 37 | steatitis | KG + DL |
| 38 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
| 39 | generalized bulbospinal muscular atrophy | KG + DL |
| 40 | ariboflavinosis | KG + DL |
| 41 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 42 | nephrolithiasis susceptibility caused by SLC26A1 | KG + DL |
| 43 | intestinal obstruction | KG + DL |
| 44 | distal hereditary motor neuropathy | KG + DL |
| 45 | deficiency anemia | KG + DL |
| 46 | spinal atrophy-ophthalmoplegia-pyramidal syndrome | KG + DL |
| 47 | bile duct disease | KG + DL |
| 48 | biliary tract disease | KG + DL |
| 49 | scrapie | KG + DL |
| 50 | neuronal intestinal dysplasia, type B | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.